Press Releases about Astrazeneca Plc ADR
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
Today 6:02 EDT
Via AB Newswire
Topics
Economy
Exposures
Interest Rates
From AstraZeneca
Via Business Wire
From Brodsky & Smith LLC
Via GlobeNewswire
Actinium Pharmaceuticals (ATNM): A Prime Buyout Candidate Amidst a Radiopharma Acquisition Wave
March 26, 2024
Via AB Newswire
Topics
Intellectual Property
Exposures
Intellectual Property
From Brodsky & Smith LLC
Via GlobeNewswire
AstraZeneca Full year and Q4 2023 Financial Results
February 08, 2024
From AstraZeneca
Via Business Wire
Markets suddenly price Eli Lilly stock for a breakout on earnings
February 05, 2024
Via MarketBeat
From Brodsky & Smith LLC
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.